These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9055761)

  • 21. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Insulin pumps].
    Charles E
    Rev Infirm; 2005 Nov; (115):21-2. PubMed ID: 16375242
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
    Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M
    Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The daily life of the insulin-dependent diabetic treated with the insulin pump].
    Lassmann-Vague V; Vialettes B; Vague P
    Rev Prat; 1986 Jun; 36(31):1813-20. PubMed ID: 3749752
    [No Abstract]   [Full Text] [Related]  

  • 25. [Implantable fixed continuous flow pumps in type I diabetes (insulin-dependent diabetes)].
    Irsigler K; Kritz H; Najemnik C; Hagmüller G; Lovett R
    Journ Annu Diabetol Hotel Dieu; 1983; ():65-78. PubMed ID: 6645142
    [No Abstract]   [Full Text] [Related]  

  • 26. Continuous subcutaneous insulin infusion.
    American Diabetes Association
    Diabetes Care; 2000 Jan; 23 Suppl 1():S90. PubMed ID: 12017692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of abdominal location of the catheter on the efficacy of intraperitoneal insulin infusion using implantable and programmable pumps in type I diabetes.
    Pinget M; Jeandidier N; Keipes M; Louy S; Vetter A
    Transplant Proc; 1992 Jun; 24(3):945-6. PubMed ID: 1604676
    [No Abstract]   [Full Text] [Related]  

  • 28. [New approaches to the therapy of insulin-dependent diabetes mellitus].
    Galimberti G; Petrella G; Micossi P; Pozza G
    Ann Ital Med Int; 1987; 2(2):158-64. PubMed ID: 3079448
    [No Abstract]   [Full Text] [Related]  

  • 29. Intensive insulin therapy and insulin pumps.
    Bode BW
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):17-21. PubMed ID: 19667601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current approaches to continuous insulin replacement for insulin-dependent diabetes: pancreas transplantation and pumps.
    Westphal SA; Goetz FC
    Adv Intern Med; 1990; 35():107-37. PubMed ID: 2105573
    [No Abstract]   [Full Text] [Related]  

  • 31. Mycobacterium fortuitum infection in continuous subcutaneous insulin infusion sites.
    López Aventín D; Rubio González B; Petiti Martín G; Segura S; Rodríguez-Peralto JL; Riveiro-Falkenbach E; Puig J; Pujol RM
    Br J Dermatol; 2014 Aug; 171(2):418-20. PubMed ID: 24588257
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
    Hoogma RP; Schumicki D
    Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Insulin pumps for insulin-dependent diabetics].
    Millet P; Selam JL; Boudet C
    Annee Ther Clin Ophtalmol; 1983; 34():99-109. PubMed ID: 6679709
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intraperitoneal insulin therapy. High tech for treatment of type 1 diabetes].
    Liebl A
    MMW Fortschr Med; 2000 May; 142(21):52-4. PubMed ID: 10872295
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nursing of diabetic patients treated by continuous subcutaneous insulin infusion].
    Li YQ; Wang DQ
    Zhonghua Hu Li Za Zhi; 1985 Aug; 20(4):215-6. PubMed ID: 3849992
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study.
    Giménez M; Conget I; Nicolau J; Pericot A; Levy I
    Acta Diabetol; 2007 Mar; 44(1):34-7. PubMed ID: 17357884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation after one year of portable insulin infusion pumps].
    Solal PC; Bertoglio J; Cupelli C
    Soins; 2004 Sep; (688):21-2. PubMed ID: 15515843
    [No Abstract]   [Full Text] [Related]  

  • 39. Insulin infusion pumps: new solution to an old problem.
    Childs BP
    Nursing; 1983 Nov; 13(11):54-7. PubMed ID: 6355927
    [No Abstract]   [Full Text] [Related]  

  • 40. [Remission of recently-appearing insulin-dependent diabetes mellitus: value of continuous infusion of insulin].
    Arlot S; Lalau JD; Mesmacque A; Quichaud J
    LARC Med; 1984 Oct; 4(8):475-8. PubMed ID: 6513704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.